Online Pain Neuroscience Education for Women With Primary Dysmenorrhea

NCT07237802 — Not applicable, Completed, 82 participants, Cardenal Herrera University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Efficacy of an Online Pain Neuroscience Education Intervention in Women With Primary Dysmenorrhea: A Randomized Controlled Trial

RegistryNCT07237802
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment82 (Actual)
SponsorCardenal Herrera University (Other)
ConditionsPrimary Dysmenorrhea (PD)
InterventionsPNE online + lifestyle recommendations., Lifestyle recommendations (Other)
Datesstart 2025-09-01, primary completion 2026-02-28, completion 2026-02-28, first posted 2025-11-20, last updated 2026-04-17
Locations1 site in Spain

Related Papers Related Patents Related Grants Related Experts
All trials for Primary Dysmenorrhea (PD) All trials of PNE online + lifestyle recommendations. All trials of Lifestyle recommendations

-Summary

Primary dysmenorrhea is a highly prevalent condition characterized by recurrent menstrual pain in the absence of identifiable pelvic pathology. It affects up to 95% of menstruating women and often interferes with quality of life. Pain neuroscience education (PNE) has shown positive effects in musculoskeletal conditions but has not yet been studied in women with primary dysmenorrhea. This study aims to evaluate the effect of an online PNE intervention combined with lifestyle recommendations, compared to lifestyle recommendations alone

Expand all sections  ·  Collapse all

+Detailed description

This randomized controlled trial will compare an online pain neuroscience education (PNE) program plus lifestyle recommendations with lifestyle recommendations alone in women with primary dysmenorrhea. Participants will be randomized (1:1) to either the intervention group (4-week online PNE modules plus lifestyle recommendations) or the control group (lifestyle recommendations only). The program is based on Butler and Moseley's pain neuroscience principles, adapted to menstrual pain. Outcomes will be assessed at baseline and at 6 months. The primary outcome is pain intensity. Secondary outcomes include anxiety, depression, kinesiophobia and pain catastrophizing,

+Arms and interventions

ArmTypeInterventionsDescription
Online Pain Neuroscience Education (PNE)ExperimentalOther: PNE online + lifestyle recommendations.Participants in this arm will receive an online pain neuroscience education (PNE) program plus usual lifestyle recommendations. The PNE intervention consists of four weekly audiovisual and written modules adapted to the context of primary dysmenorrhea, focusing on the neurobiology and biopsychosocial aspects of pain, with practical strategies to reduce maladaptive beliefs, kinesiophobia, and catastrophizing.
Active ComparatorActive comparatorOther: Lifestyle recommendationsParticipants in this arm will receive the usual lifestyle recommendations for primary dysmenorrhea. These recommendations include general advice on healthy habits and self-management strategies typically provided in clinical practice.
  • PNE online + lifestyle recommendations. (Other): Four-week online educational program with audiovisual modules on the neurobiology and biopsychosocial aspects of pain, adapted to women with primary dysmenorrhea. In addition, participants receive usual lifestyle recommendations, including general advice on healthy habits and self-management strategies commonly provided in clinical practice.
  • Lifestyle recommendations (Other): Participants in this arm will receive online lifestyle recommendations for four weeks, including general advice on healthy habits and self-management strategies commonly provided in clinical practice for women with primary dysmenorrhea.

+Outcome measures

Primary outcomes

  • Pain intensity measured by the 11-point Numeric Rating Scale (NRS) [pre-intervention and 6 months post-intervention]: Pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS). Participants will rate their average menstrual pain intensity over the previous cycle, from 0 ("no pain") to 10 ("worst imaginable pain"). Higher scores indicate greater pain intensity.

Secondary outcomes

  • Anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS) [pre-intervention and 6 months post-intervention]: The Hospital Anxiety and Depression Scale (HADS) has 14 items, with two subscales: HADS-Anxiety (7 items) and HADS-Depression (7 items). Each subscale ranges 0-21; higher scores indicate greater anxiety/depression.
  • Kinesiophobia measured by the Tampa Scale for Kinesiophobia-11 (TSK-11) [pre-intervention and 6 months post-intervention]: The Tampa Scale for Kinesiophobia-11 (TSK-11) has 11 items scored 1 ("strongly disagree") to 4 ("strongly agree"). Total score 11-44; higher scores indicate greater fear of movement/re-injury.
  • Pain catastrophizing measured by the Pain Catastrophizing Scale (PCS) [pre-intervention and 6 months post-intervention]: The Pain Catastrophizing Scale (PCS) includes 13 items scored 0 ("not at all") to 4 ("all the time"). Total score 0-52; higher scores indicate greater pain catastrophizing.

+Eligibility

Sex: Female, ages: 18 Years to 35 Years

Inclusion Criteria:

* Nulliparous women aged 18 to 35 years.
* Clinical diagnosis of primary dysmenorrhea.
* History of moderate to severe menstrual pain for at least six consecutive menstrual cycles.
* Pain intensity score greater than 5 on a numerical rating scale (0-10).
* No prior use of pain neuroscience education (PNE).
* No history of pregnancy.

Exclusion Criteria:

* History of lower abdominal surgery.
* Presence of severe mental health disorders.
* Current use of hormonal contraceptives.

+Locations (1)

FacilityCityCountryStatus
Universidad CEU Cardenal HerreraValencia, Valencia-valènciaSpain

+Publications

  • Soderman L, Edlund M, Marions L. Prevalence and impact of dysmenorrhea in Swedish adolescents. Acta Obstet Gynecol Scand. 2019 Feb;98(2):215-221. doi: 10.1111/aogs.13480. Epub 2018 Nov 6. PMID 30312470
  • Butler DS, Moseley GL. Explain Pain. 2nd ed. Adelaide, South Australia: Noigroup Publications; 2013.

+Investigators

  • Juan Francisco Lisón Párraga, Dr, Principal investigator, Universidad Cardenal Herrera CEU